Discussions on Industry News
- InSite Vision Commences Phase 1/2 Clinical Study of ISV-303 for Post-Surgical Ocular Pain and Swelling Following Cataract and Other Surgeries
- Is Iluvien From Alimera Sciences the Future of Ophthalmic Drug Delivery?
- Updated Clinical Results for Ellex 2RT Laser Therapy
- The Story Behind the Invention of Avastin and Lucentis
- Potential Breakthrough in Creating Artificial Retina from Human Embryonic Stem Cells
- On Demand Therapeutics Announces Novel Drug Delivery System for AMD
- The Notal Vision At Home Monitor for AMD
- The London Project To Cure Blindness – An Update
- Synchrony IOL Gives Almost 3D of Accomodation
- pSivida Announces Positive Results From The Two Phase 3 FAME™ Trials of Iluvien in Patients With Diabetic Macular Edema
- An Overview of New Treatments for Dry AMD
- Color-Changing Contact Lenses To Replace Blood Tests for Diabetics
- The First Ophthalmic Innovation Summit
- Oraya IRay In-office Stereotactic X-ray Treatment for AMD: A First Report
- NeoVista Rolls Out Novel Treatment for AMD Using Radiation
- CMS Reverses the Reimbursement for AVASTIN
- More AAO Highlights: Steroid implants for DME, Gene Therapy for Retinal Dystrophy, and More
- AAO Highlights: Lasers for Cataract Surgery, Laser Vision Correction Trends, and More
- Ellex Unveils New Diagnostic Ultrasound System at AAO
- Lux Biosciences’ Voclosporin Phase II/III Results Presented at AAO
- NeoVista®, Inc. Completes Enrollment in Pivotal CABERNET™ Study
- New Glasses Will Project Images Directly Onto the Retina
- CMS Reverses Position on Avastin for AMD
- Interesting News from the 2009 AAO Meeting from Ellex, NeoVista, Presbia and Others
- Aerie Pharmaceuticals’ AR-12286 Shows Positive Results in Glaucoma Patients in a Phase 2a Study
- Update on Avastin vs. Lucentis: CMS Ups the Ante
- Roche and Genentech Strike Deal With Surmodics For Biodegradable Microparticle Drug Delivery System for Lucentis
- Alimera Reports Results of Study of Iluvien for Diabetic Macular Edema
- Endo Optiks Introduces New High Resolution Endoscopes
- Can the Blood Vessels in Your Retina Predict Your Risk of Heart Disease?
- ThromboGenics Completes Patient Enrollment in Microplasmin Trial
- Alimera Sciences Announces Study of Iluvien® in Patients With Macular Edema Due to Retinal Vein Occlusion
- Zirgan™ for Herpes Keratitis from Sirion Therapeutics Approved by FDA
- ISTA Pharmaceuticals’ Bepreve™ Receives FDA Approval For Ocular Itching Associated With Allergic Conjunctivitis
- LenSx Obtains First Femtosecond Laser Approval for Capsulotomies
- Stemedica Applies for Patent Application for Diabetic Retinopathy Treatment
- Does Pseudo 2D Fractal Analysis Improve Detection of Retinal Disease?
- Will Electronic Contact Lens Make Bionic Vision a Reality?
- Can GS-101 Prevent Corneal Transplant Rejection?
- Abbott to Acquire Visiogen and Enlarge Ophthalmic Portfolio
- R-Tech Ueno Completes Enrollment in Phase 2 Clinical Study for the Agent UF-021
- ISTA Pharmaceuticals Announces Positive Results for Xibrom
- Resolvyx Announces Positive Data from Trial of Resolvin RX-10045 for Dry Eye
- Microneedle Patch Delivers Drugs to Eye Without Pain
- Aton Pharma Launches Extended Program for Preservative-Free Timoptic® in Ocudose®
- Sylentis to Start Clinical Trial of SYL040012 for the Treatment of Ocular Hypertension
- Gene Signal Announces Publication of Data on GS-101, Start of Phase III Study to Prevent Corneal Neovascularization
- Are TruFocals An Option for Presbyopia?
- NicOx Reacquires Rights to Glaucoma Drug From Pfizer
- SOLX Gold Shunt Cleared in Canada for Surgical Treatment of Glaucoma
- SENSIMED Triggerfish Electronic Contact Lens Continually Monitors Eye Pressure
- QLT Announces Interim Data for Phase 2 Punctal Plug Delivery System Clinical Trial
- Regeneron Commence Study of VEGF Trap-Eye for CVRO Treatment
- Acuvail™ From Allergan Receives FDA Approval for Post-Cataract Surgery Treatment
- PolyMedix Receives Patent for Compounds for Angiogenesis Inhibitors
- New EyeCon Eye Dropper Device From Japan Never Misses the Target
- OcuCure Therapeutics Eye Drop Shows Efficacy in Primates for AMD
- New Glaucoma Drug from Canadian Bio Med Systems and Ocular Therapeutics Pique Interest of Large Pharma Firms
- OXiGENE Announces Plans to Acquire Symphony ViDA Along With Rights to ZYBRESTAT™ for Ophthalmology
- Technolas Eyetracking Technology Approved For LASIK Surgery by FDA
- Alcon Starts Phase 2 Trial of NovaBay’s NVC-422 for Viral Conjunctivitis
- New Laser Treatment to Halt Blindness
- Lucentis Improves Vision in Retinal Vein Occlusions
- MatchedFlicker Software for Early Glaucoma Diagnosis Receives FDA Clearance
- Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction in Glaucoma Patients
- Stemedica Cell Technologies Announces Breakthrough Discovery in Use of Stem Cells for Treating Retinal Degeneration
- Bepreve™ Eye Drops from ISTA Obtain Approval of FDA Dermatologic and Ophthalmic Drugs Advisory Committee
- OXiGENE Starts ZYBRESTAT Phase 2 Study for Treatment of Polypoidal Choroidal Vasculopathy
- Inotek Pharmaceuticals Announces Positive Results for INO-8875 in Phase I/II Glaucoma Study
- RegeneRx Biopharmaceuticals, Inc. Plans Test of TB4 Eye Drops to Reduce Chemical Eye Damage
- Advanced Cell Technology, OHSU Researchers Show Safety, Efficacy of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigment Epithelium (RPE)
- FDA Finds Bepreve Eye Drops from ISTA Effective At Treating Itching from Allergies, But Questions Data For Rejena Eye Drops for Treating Dry Eye
- Transcend Medical Raises $35 Million for Development of CyPass Glaucoma Treatment System
- EyeIC Raises Funds to Market MatchedFlicker Software for Glaucoma Diagnosis
- Allergan Announces FDA Approval for OZURDEX™ For Treatment of Macular Edema Following Branch Retinal Vein Occlusion or Central Retinal Vein Occlusion
- Can Femtosecond Lasers Be Used for Cataract Surgery?
- Future Applications of the Femtosecond Laser
- QLT Announces Positive Results from Visudyne-Lucentis Combination Therapy for Wet AMD
- Carl Zeiss Meditec Receives FDA Clearance for Cirrus HD-OCT Software Version 4.0
- Palomar Medical Technologies Secures OTC Clearance from FDA for Home Use Laser To Treat Eye Wrinkles
- Can Femtosecond Laser Be Used to Correct Myopia?
- Implantable Contact Lenses for Myopia
- FDA Approves Besifloxacin Drops for Treatment of Bacterial Conjunctivitis
- Summary of Surgical Techniques to Correct Presbyopia
- FDA Says LASIK Ads Must Warn Consumers of Side Effect Risks
- Bausch & Lomb Akreos® AO IOL Granted New Technology Intraocular Lens (NTIOL) Designation
- FDA Grants Accelerated Approval of Avastin for Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy
- Visiogen Raises $40 Million to Support Global to Support the Global Commercialization of the Synchrony Dual Optic Accommodating Intraocular Lens
- IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems
- B&L and 20/10 Perfect Vision form Technolas Perfect Vision
- Bayer and Regeneron Expand VEGF Trap-Eye to CRVO
- OptiMedica Corp. Presentations at ARVO 2009 to Cover PASCAL Laser Technology
- TransMolecular, Inc. Presentation at ARVO 2009
- Sirion Therapeutics Presentation at ARVO 2009
- ARVO 2009 Presentations – StemCells, Inc.
- Inotek Pharmaceuticals Presentations at ARVO 2009
- pSivida Corp Presentations at ARVO 2009
- Resolvyx Pharmaceuticals Presentations at ARVO 2009
- Santen and Merck Sign Licensing Agreement for Tafluprost Treatment for Glaucoma and Ocular Hypertension
- Othera Pharmaceuticals Announces Positive Interim Phase 2 Results of OT-551 Eye Drop Treatment for Dry AMD
- Ophthalmologists Opposing Legislation in at Least Five States Seeking to Expand Optometrists’ Scope of Practice
- Synchrony Accomodative Lens- Just One Diopter
- LensX Lasers Raises $22.36 Million for Cataract Laser
- Implantable Miniature Telescope for AMD From VisionCare Ophthalmic Technologies Secures Approval From FDA Ophthalmic Devices Advisory Panel
- Inlays, Onlays, Rings & Things
- Neurotech Reports NT-501 Substantially Slowed Loss of Vision in Subjects With Dry AMD Involving Geographic Atrophy
- NeoVista Raises $18 Million to Fund Continued Clinical Trials of Beta Radiation Therapy for Wet AMD
- Lux Biosciences Completes Patient Enrollment in LUCIDA Phase 3 Program for LUMITECT for Prevention of Corneal Transplant Rejection
- Advanced Cell Technology Ready to File Independent New Drug Application for Stem Cell Based Program for Treating Retinal Diseases
- Opko Health Terminates Late-Stage Trial Of Bevasiranib For Treatment Of Wet Age-Related Macular Degeneration
- Blind Man Fitted With Argus II Bionic Eye from Second Sight Now Sees Light
- Alcon AcrySof® IQ Toric IOL Approved for U.S. Patients with Cataracts and Astigmatism
- Pfizer Ophthalmics and Bausch & Lomb Announce Co-Promotion Agreement Covering Xalatan, Alrex, Lotemax and Zylet
- BiCOM Announces Diaton Tonometer For Measuring Intraocular Pressure Through Eyelid Approved by Mexico Ministry of Health
- Novagali Pharma Releases Data Pertaining to BAK-Free Eye Drops for Glaucoma Treatment
- Abbott Labs Completes Purchase of Producer of Advanced Refractive Technologies
- EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
- Aton Pharma Acquires Marketing Rights to Preservative-Free Timolol Product Line from Merck
- FDA Grants NeoVista’s Request to Utilize Novel Wet AMD Treatment in Compassionate Case
Subscribe for Free!
